Laura Carrassa
Ospedale San Donato(IT)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, DNA Repair Mechanisms, PI3K/AKT/mTOR signaling in cancer, Protein Degradation and Inhibitors, Radiopharmaceutical Chemistry and Applications
Most-Cited Works
- → DNA damage response inhibitors: Mechanisms and potential applications in cancer therapy(2017)174 cited
- → Unique pattern of ET-743 activity in different cellular systems with defined deficiencies in DNA-repair pathways(2001)160 cited
- → PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy(2017)117 cited
- → Combined inhibition of Chk1 and Wee1: In vitro synergistic effect translates to tumor growth inhibition in vivo(2012)113 cited
- → Cisplatinum and Taxol Induce Different Patterns of p53 Phosphorylation(2001)93 cited
- → Unleashing Chk1 in cancer therapy(2011)82 cited
- → Chk1, but not Chk2 , is Involved in the Cellular Response to DNA Damaging Agents: Differential Activity in Cells Expressing, or not, p53(2004)80 cited
- → The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents(2019)69 cited
- → Recent Insights into Mucinous Ovarian Carcinoma(2018)66 cited
- → Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma(2014)62 cited